Newborn brain cells provide a possible treatment for epilepsy
Scientists gained new insights into how immature astroglia might contribute to epilepsy, opening research towards developing new anti-seizure medications.
List view / Grid view
Scientists gained new insights into how immature astroglia might contribute to epilepsy, opening research towards developing new anti-seizure medications.
Read this bulletin to learn about a Bio-Rad study where they developed and tested a 16-parameter flow cytometry panel applicable to the interrogation of a range of biologically relevant markers of T cell activation.
A review of current challenges and goals in cardiac drug discovery and how innovations on human iPSC technology are helping to overcome them.
Do you know how much time your lab spends on pipetting tasks daily? If not you can easily find out. Just answer four simple questions, then Flow Robotics' calculator can give you a full report on how your lab is doing in minutes.
Pre-clinical research in newborn rats found that a nanotherapy could prevent chronic lung disease in premature babies.
Precision medicine in neurology is limited by a dearth of clinically relevant models. However, here Dr Evangelos Kiskinis, Assistant Professor at Northwestern University Feinberg School of Medicine, discusses how new technologies such as bioelectronic assays enable real-time, long-term analysis of neurological diseases in a dish, offering a pathway towards identifying…
Researchers have developed a new method to screen drugs for Alzheimer’s disease, shedding light on why current drugs have failed and identifying novel drug targets.
A new study from Niigata University has found a binding protein that is vital for proper development of the central nervous system.
Scientists have discovered the essential role of a ligand-dependent corepressor to potentially enable cancer cells to present tumour antigens on their surfaces.
A new study led by the Indiana University School of Medicine showed human induced pluripotent stem cells can improve visual acuity, vascular health and other complications related to type 2 diabetes.
New research by the Salk Institute has shown cellular rejuvenation therapy safely reverses signs of ageing in mice.
Scientists have gained deeper knowledge about the mislocalisation of a protein, providing a possible therapeutic target that could have implications in treating dementia.
An iPSC technology leader taps industry veteran to drive growth in cell therapy and drug discovery markets.
Long-awaited findings about cell differentiation will be relevant in understanding normal development and may also be useful in cancer research.
Researchers have successfully generated organoids in suspension, offering the possibility of larger-scale experiments to study human development and disease.